LEGN logo

Legend Biotech Corporation (LEGN) Free cash flow

annual FCF:

-$210.31M+$295.66M(+58.43%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LEGN annual free cash flow is -$210.31 million, with the most recent change of +$295.66 million (+58.43%) on December 31, 2024.
  • During the last 3 years, LEGN annual FCF has risen by +$34.20 million (+13.99%).
  • LEGN annual FCF is now -173.37% below its all-time high of $286.66 million, reached on December 31, 2018.

Performance

LEGN Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

quarterly FCF:

-$22.27M+$83.49M(+78.95%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN quarterly free cash flow is -$22.27 million, with the most recent change of +$83.49 million (+78.95%) on June 30, 2025.
  • Over the past year, LEGN quarterly FCF has dropped by -$17.20 million (-339.34%).
  • LEGN quarterly FCF is now -211.63% below its all-time high of $19.95 million, reached on September 30, 2019.

Performance

LEGN quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

TTM FCF:

-$290.37M-$17.20M(-6.30%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN TTM free cash flow is -$290.37 million, with the most recent change of -$17.20 million (-6.30%) on June 30, 2025.
  • Over the past year, LEGN TTM FCF has dropped by -$125.75 million (-76.40%).
  • LEGN TTM FCF is now -1158.19% below its all-time high of -$23.08 million, reached on September 30, 2019.

Performance

LEGN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

LEGN Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.4%-339.3%-76.4%
3 y3 years+14.0%-61.0%-31.6%
5 y5 years-72.1%+73.4%-39.2%

LEGN Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+58.4%-340.1%+84.5%-83.6%+30.2%
5 y5-year-72.1%+58.4%-340.1%+84.5%-83.6%+30.2%
alltimeall time-173.4%+58.4%-211.6%+84.5%-1158.2%+30.2%

LEGN Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$22.27M(-78.9%)
-$290.37M(+6.3%)
Mar 2025
-
-$105.76M(+25.2%)
-$273.17M(+72.7%)
Dec 2024
-$210.31M(-58.4%)
-$84.46M(+8.4%)
-$158.14M(-10.2%)
Sep 2024
-
-$77.89M(+1436.8%)
-$176.18M(+7.0%)
Jun 2024
-
-$5.07M(-154.7%)
-$164.61M(-37.5%)
Mar 2024
-
$9.27M(-109.0%)
-$263.24M(-36.7%)
Dec 2023
-$505.97M(+113.4%)
-$102.49M(+54.5%)
-$416.00M(+12.2%)
Sep 2023
-
-$66.32M(-36.0%)
-$370.77M(-2.0%)
Jun 2023
-
-$103.69M(-27.7%)
-$378.22M(+31.2%)
Mar 2023
-
-$143.49M(+150.6%)
-$288.36M(+29.0%)
Dec 2022
-$237.10M(-3.0%)
-$57.26M(-22.4%)
-$223.56M(-5.8%)
Sep 2022
-
-$73.78M(+433.5%)
-$237.28M(+7.5%)
Jun 2022
-
-$13.83M(-82.4%)
-$220.71M(-25.4%)
Mar 2022
-
-$78.69M(+10.8%)
-$295.77M(+21.3%)
DateAnnualQuarterlyTTM
Dec 2021
-$244.52M(-10.5%)
-$70.99M(+24.1%)
-$243.87M(+8.3%)
Sep 2021
-
-$57.20M(-35.6%)
-$225.09M(-6.0%)
Jun 2021
-
-$88.89M(+231.8%)
-$239.53M(+2.2%)
Mar 2021
-
-$26.79M(-48.7%)
-$234.28M(-7.5%)
Dec 2020
-$273.08M(+123.4%)
-$52.21M(-27.1%)
-$253.29M(-15.6%)
Sep 2020
-
-$71.65M(-14.3%)
-$300.24M(+43.9%)
Jun 2020
-
-$83.64M(+82.6%)
-$208.64M(+44.5%)
Mar 2020
-
-$45.80M(-53.8%)
-$144.34M(+18.1%)
Dec 2019
-$122.23M(-142.6%)
-$99.16M(-597.1%)
-$122.23M(+429.7%)
Sep 2019
-
$19.95M(-203.1%)
-$23.08M(-46.4%)
Jun 2019
-
-$19.34M(-18.4%)
-$43.02M(+81.6%)
Mar 2019
-
-$23.69M
-$23.69M
Dec 2018
$286.66M(-8885.2%)
-
-
Dec 2017
-$3.26M
-
-

FAQ

  • What is Legend Biotech Corporation annual free cash flow?
  • What is the all time high annual FCF for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual FCF year-on-year change?
  • What is Legend Biotech Corporation quarterly free cash flow?
  • What is the all time high quarterly FCF for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly FCF year-on-year change?
  • What is Legend Biotech Corporation TTM free cash flow?
  • What is the all time high TTM FCF for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM FCF year-on-year change?

What is Legend Biotech Corporation annual free cash flow?

The current annual FCF of LEGN is -$210.31M

What is the all time high annual FCF for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual free cash flow is $286.66M

What is Legend Biotech Corporation annual FCF year-on-year change?

Over the past year, LEGN annual free cash flow has changed by +$295.66M (+58.43%)

What is Legend Biotech Corporation quarterly free cash flow?

The current quarterly FCF of LEGN is -$22.27M

What is the all time high quarterly FCF for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly free cash flow is $19.95M

What is Legend Biotech Corporation quarterly FCF year-on-year change?

Over the past year, LEGN quarterly free cash flow has changed by -$17.20M (-339.34%)

What is Legend Biotech Corporation TTM free cash flow?

The current TTM FCF of LEGN is -$290.37M

What is the all time high TTM FCF for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM free cash flow is -$23.08M

What is Legend Biotech Corporation TTM FCF year-on-year change?

Over the past year, LEGN TTM free cash flow has changed by -$125.75M (-76.40%)
On this page